ישראל -
עברית -
Ministry of Health
pnm 60-digital retinoscope
medibell ltd. - רופא - מכשיר לצילום רשתית העין
ישראל -
עברית -
Ministry of Health
panoret 1000+panoret 1000a+panoret1000m
medibell ltd. - רופא - המכשיר משמש לבדיקות איבחון של רשתית העין בזוויות רחבה ע'י תאורה בלתי ישירה המאפשרת לקבל תמונה פנורמית של קרקעית העין ללא צורך בהרחבת האישון.
ישראל -
עברית -
Ministry of Health
אוקרוואס
roche pharmaceuticals (israel) ltd - ocrelizumab - תרכיז להכנת תמיסה לאינפוזיה - ocrelizumab 30 mg/ml - ocrelizumab
ישראל -
עברית -
Ministry of Health
surgical drapes (disposable)
medicell import ltd. - אחות - כיסויים סטריליים חד פעמיים
ישראל -
עברית -
Ministry of Health
phyisioglove es
commwell research&dev - מומחה - כפפה פיזיולוגית לאבחון א.ק.ג.
ישראל -
עברית -
Ministry of Health
רביף 22 מקג
merck serono ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 44 mcg/ml - interferon beta-1a - interferon beta-1a - rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. efficacy of rebif in chronic progressive multiple sclerosis has not been established.
ישראל -
עברית -
Ministry of Health
אוונקס תמיסה להזרקה
medison pharma ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 30 mcg / 0.5 ml - interferon beta-1a - interferon beta-1a - treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.
ישראל -
עברית -
Ministry of Health
בטאפרון
bayer israel ltd - interferon beta 1b - אבקה וממס להכנת תמיסה להזרקה - interferon beta 1b 0.3 mg/vial - interferon beta-1b - interferon beta-1b - use in ambulatory patients with relapsing-remitting multiple sclerosis (rrms) and relapsing progressive m.s. to reduce the frequency of clinical exacerbations. treatment of secondary progressive (sp) form of multiple sclerosis. treatment of patients who have experienced a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, including the prescence of mri abnormalities characteristic of m.s. and if they are determined to be at high risk of developing clinically definite multiple sclerosis.